Recombinant human α-klotho
1 paper2 findings
- 1 lab
- Humans1
Outcomes
2Osteogenic differentiation
downin human cells1
1 study
Osteogenic differentiation
downin human cells1
Recombinant human α-klotho inhibits osteogenic differentiation in human cells.
“inhibited osteogenic differentiation.”
Cellsin VICs
Endogenous α-Klotho is a common target in atherosclerosis and calcific aortic valve disease
Biochemical pharmacology28 Mar 2026
Inflammation
downin human cells1
1 study
Inflammation
downin human cells1
Recombinant human α-klotho decreases inflammation in human cells.
“rKlotho attenuated inflammation and inhibited osteogenic differentiation.”
Cellsin VSMCs and VICs
Endogenous α-Klotho is a common target in atherosclerosis and calcific aortic valve disease
Biochemical pharmacology28 Mar 2026
Latest
1 in 12 monthsBiochemical Pharmacology
Endogenous α-Klotho is a common target in atherosclerosis and calcific aortic valve disease
Cross-sectional study of 172 peopleKL